News and Trends 7 Sep 2022 Could COVID vaccine boosters become obsolete? …the original strain) are actually very effective in neutralizing the Delta and Omicron variants. According to our findings, the effectiveness of the first antibody, TAU-1109, in neutralizing the Omicron strain… September 7, 2022 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 21 Dec 2021 Argenx’s Potential Blockbuster Gets FDA Nod for Autoimmune Disease …marketed as Vyvgart, is an antibody fragment drug for use in adults with generalized myasthenia gravis. The FDA’s decision represents the first successful drug approval for argenx. According to Evaluate… December 21, 2021 - 4 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
More News! 17 Jul 2024 Is tau protein the key to defeating Alzheimer’s? Asceneuron thinks so and raises $100 million to prove it …candidate targeting tau proteins associated with Alzheimer’s disease. Asceneuron’s approach to tackling Alzheimer’s disease sets it apart in the competitive landscape of neurodegenerative disease treatments. While approved therapies for Alzheimer’s,… July 17, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 13 Mar 2023 New therapy for prevention and treatment of COVID-19 …a novel, highly potent, anti-S2 camelid single-domain antibody, discovered at the VIB-UGent Center for Medical Biotechnology, which was developed as a candidate drug molecule by ExeVir Bio as XVR013. It… March 13, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 13 Dec 2024 Is China the future of biotech? …Chinese companies were biologics. The report notes that the number of antibody drug conjugate (ADC), bispecific antibody, and CAR-T pipelines has increased by seven, five, and four times, respectively. The… December 13, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 6 Jun 2023 Shasqi using click chemistry to target cancer …antibody drug conjugates,” said Mukul Agarwal, chief business officer at Shasqi. “The reliance on chemistry, not biology for drug activation, allows for the use of small molecules, peptides, and antibody… June 6, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 7 Sep 2022 OncoResponse and Regeneron to evaluate drug combo for patients with advanced cancer …in a separate biology cohort. About OR2805 OR2805 is a fully human antibody discovered using B cells derived from an elite responder to checkpoint inhibitor (CPI) therapy. This antibody binds… September 7, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 24 Mar 2025 First-ever RIPTAC enters clinic: all you need to know about this new cancer approach …antibody-drug conjugates (ADCs), which are composed of a monoclonal antibody, a cytotoxic drug – typically a chemotherapy – and a linker. But unlike ADCs, which deliver the drug specifically to… March 24, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 12 Aug 2022 argenx secures European Commission approval for generalized myasthenia gravis treatment …generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive. The approval is applicable to all 27 European Union (EU) Member States plus Iceland, Norway and Liechtenstein. argenx said… August 12, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 16 May 2023 LabGenius looks to create molecules with huge increase in tumor killing ability LabGenius, which uses machine learning (ML) for antibody discovery, has presented data in a poster presentation at the Protein Engineering and Biotherapeutics (PEGS) annual meeting. The data were from LabGenius’… May 16, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Sponsored by KBI Biopharma 16 Jul 2024 How a microbial expression update is driving biotech innovation …to prepare for future applications, including antibody fragments and therapeutic peptides. While microbial protein production systems present cost-efficient alternatives to insect or mammalian cells, the commonly used E. coli strains… July 16, 2024 - 7 minutesmins - By Ute Boronowsky Share WhatsApp Twitter Linkedin Email
News and Trends 25 Nov 2021 Despite New Approvals, Covid-19 Treatments Lag Behind Vaccines …the European Commission gave its stamp of approval to two antibody treatments for Covid-19: regdanvimab from the South Korean firm Celltrion Healthcare, and a blend of two antibodies called casirivimab… November 25, 2021 - 6 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email